Dr Reddys Laboratories Share Price Today - Live Blog for October 06, 2025

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.09% increase and currently trading at ₹1,249.45 per share. Investors are taking notice of this upward momentum.

Demonstrating a commendable 0.14% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,249.40. In terms of valuation, the stock maintains a PE ratio of 18.3400, while the industry PE ratio stands at 34.3345.

After a significant 0.06% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,247.30 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.03% upswing, and it's currently trading at ₹1,247.15 per share. Investors are closely watching this development.

The share price of Dr Reddys Laboratories Ltd experienced a -0.00% slump and is currently trading at ₹1,246.70. While the stock maintains a PE ratio of 18.3400, the industry PE is 34.3345, raising questions about valuation.

Dr Reddys Laboratories Ltd share price has declined by -0.08%, and it's currently trading at ₹1,246.45. The stock maintains a PE of 18.3400, while the industry PE is 34.3345, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd experienced a -0.03% dip in its share price and is currently trading at ₹1,246.00. The stock has a PE ratio of 18.3400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.00%, signalling a challenging period. Currently trading at ₹1,247.65, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd witnessed a substantial 0.26% increase in its share price and is currently trading at ₹1,248.45. This remarkable performance has caught the eye of investors.

Dr Reddys Laboratories Ltd shares experienced a -0.12% reduction, with the current market price at ₹1,244.40. Investors are carefully considering their positions and seeking insights into the stock's future performance.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.09% increase and currently trading at ₹1,246.00 per share. This upward trajectory is turning heads in the market.

Dr Reddys Laboratories Ltd stock price decreased by -0.11%, with the current market value at ₹1,245.05 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.24% drop, and it's now trading at ₹1,243.85 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.24%, signalling a challenging period. Currently trading at ₹1,243.85, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.03%. At this moment, it's actively trading at ₹1,245.25, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd's share price has fallen by -0.20%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,244.90, and market participants are assessing the implications. The stock has a PE ratio of 18.3400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

After a significant 0.25% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,247.45 in the current market. This upward movement is attracting attention from both retail and institutional investors.

The stock of Dr Reddys Laboratories Ltd suffered a -0.06% decline, and it currently trades at ₹1,244.80 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.03% boost, with the current market value at ₹1,243.80 per share. This surge has not gone unnoticed by investors.

After a significant 0.25% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,243.20 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd experienced a substantial 0.25% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,243.20, making it an appealing option for investors.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.25% increase. Presently, it is actively trading at ₹1,243.20.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.25%. At this moment, it's actively trading at ₹1,243.20, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd witnessed a notable 0.16% surge in its share price and is presently trading at ₹1,240.45, captivating the attention of market participants.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.16% upswing, and it's currently trading at ₹1,240.45 per share. Investors are closely watching this development.

The share price of Dr Reddys Laboratories Ltd plunged by -0.05%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,239.15, but investors are assessing whether this is a temporary dip or a long-term trend.

With a -0.08% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,239.00. The stock is currently trading at a PE of 18.3400, while the industry PE is 34.3345, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd's stock price surged by 0.48%, reaching the current market value of ₹1,241.65 per share. This surge is a testament to the stock's recent performance.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.39% recently. As of now, this stock is actively trading at a current market price of ₹1,236.90 per share, attracting attention from investors.